Skip to main content

Table 2 Median maternal serum-PFAS concentrations (ng/ml) and (25th – 75th percentiles) according to respiratory health outcomes

From: Association between prenatal exposure to perfluoroalkyl substances and asthma in 5-year-old children in the Odense Child Cohort

Maternal serum-PFAS concentration (ng/ml) median (25th–75th percentile)

Wheeze

Self-reported Asthma

Doctor-diagnosed Asthma

 

All

n = 981

Yes

n = 182

No

n = 799

Yes

n = 25

No

n = 956

Yes

n = 44

No

n = 937

PFOS

7.73 (5.68–10.44)

7.69 (5.85–10.86)

7.73 (5.66–10.39)

8.09 (6.90–10.86)

7.72 (5.67–10.43)

7.32 (5.39–9.01)

7.73 (5.70–10.45)

PFOA

1.68 (1.13–2.35)

1.63 (1.17–2.30)

1.69 (1.11–2.36)

1.83 (1.37–2.59)

1.68 (1.12–2.34)

1.55 (1.09–1.97)

1.69 (1.13–2.37)

PFHxS

0.36 (0.24–0.50)

0.36 (0.25–0.50)

0.36 (0.24–0.50)

0.37 (0.30–0.48)

0.36 (0.24–0.50)

0.34 (0.25–0.51)

0.36 (0.24–0.50)

PFNA

0.65 (0.49–0.86)

0.66 (0.51–0.86)

0.65 (0.49–0.86)

0.75* (0.58–0.96)

0.64* (0.49–0.86)

0.61 (0.44–0.77)

0.65 (0.49–0.87)

PFDA

0.29 (0.22–0.40)

0.30 (0.22–0.43)

0.29 (0.22–0.40)

0.35 (0.19–0.46)

0.29 (0.22–0.40)

0.29 (0.22–0.39)

0.29 (0.22–0.40)

  1. * p < 0.05, using the Mann-Whitney test